Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
695.00    -6.00 (-0.86%)
Bid:
690.00
Ask:
700.00
Spread: 10.00 (1.449%)
Market Cap: £244.91m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Acquisition - Replacement

15 Aug 2014 07:00

RNS Number : 2381P
B.P. Marsh & Partners PLC
15 August 2014
 

Date: 14 August 2014

On behalf of: B.P. Marsh & Partners Plc

Immediate release

B.P. Marsh & Partners Plc

("B.P. Marsh" or "the Company")

Acquisition - Replacement

 

B.P. Marsh advises that the following replaces the Acquisition announcement released on 14 August 2014 at 12:22 under RNS number 1566P.

 

Nexus' premium income in 2013 was £55m and not £41m as stated in the original announcement.

 

All other details remain unchanged. The full amended text appears below.

 

 

B.P. Marsh & Partners Plc

("B.P. Marsh" or "the Company")

Acquisition

 

B.P. Marsh & Partners Plc (AIM: BPM), the niche venture capital provider to early stage financial services businesses, is pleased to announce that it has subscribed for a 5% Preferred Ordinary shareholding in Nexus Underwriting Management Limited ("Nexus"), the independent specialty Managing General Agency (MGA), for a total consideration of £1,554,000.

 

Founded in 2008 by Colin Thompson, its CEO and Ian Whistondale, its Chairman, Nexus has grown rapidly in the six years since inception; from a standing start it has cumulatively underwritten in excess of US$350m GWP. Colin Thompson has significant experience in the insurance sector, having previously undertaken senior roles at Axis Specialty Europe Ltd and Chubb Insurance Company of Europe SA. Ian Whistondale has over 30 years' experience in the London insurance market and has successfully founded and managed a number of profitable insurance underwriting and brokerage businesses.

 

Nexus has two operating subsidiaries, Nexus Underwriting Limited, which underwrites Speciality Insurance Products (Directors & Officers, Professional Indemnity, Financial Institutions and Accident & Health), and Nexus CIFS Limited, which specifically covers Trade Credit Insurance.

 

Nexus is one of the largest independent specialty MGAs in the London Market with a forecast Premium income in excess of £60m in 2014 (£55m in 2013). Commission income has risen from £873k in 2008 to a forecast of £13m in 2014, operating profit rising from £560k to a forecast of circa £3m over the same period.

 

B.P. Marsh considered that the opportunity to invest in a well established and fast-growing business, with on-going development potential and an experienced and ambitious management team, justified a smaller minority stake (at 5%) than is typical for the Company.

 

The investment will be used to build on Nexus' well-established position as a market leader and assist the company in its growth ambitions.

 

Commenting on the receipt of this investment, Colin Thompson, Nexus' CEO stated "B.P. Marsh have an excellent track record in supporting businesses in their development and growth. Not only does this investment ratify a valuation of over £30m but will also provide us with the opportunity to access follow on funding for future growth plans."

 

Commenting on this transaction, Brian Marsh OBE, Chairman of the Company, stated "We are very pleased to take this initial stake in Nexus, to which we are hoping to add over the months and years ahead."

 

Daniel Topping will be appointed to the Board of Nexus as the Company's nominee director, subject to FCA approval. Commenting on this investment he stated "whilst a departure from our normal investment approach the Board of B.P. Marsh saw this as an excellent opportunity to deploy capital into a fast growing, specialist insurance intermediary which should provide a good opportunity for shareholder returns."

 

This investment will bring the Company's portfolio to 11 companies and is the fourth standalone MGA to be added to the portfolio.

 

For further information:

 

B.P. Marsh & Partners Plc www.bpmarsh.co.uk

Brian Marsh OBE / Camilla Kenyon +44 (0)20 7233 3112

 

Nominated Adviser & Broker

Panmure Gordon

Fred Walsh / Charles Leigh-Pemberton / Atholl Tweedie +44 (0)20 7886 2500

 

Notes to Editors:

 

About B.P. Marsh & Partners Plc

 

B.P. Marsh's current portfolio contains eleven companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 20 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for at least five years.

 

Prior to Brian Marsh's involvement in the Company, he spent many years in insurance broking and underwriting in Lloyd's as well as the London and overseas market. He has over 30 years' experience in building, buying and selling financial services businesses, particularly in the insurance sector.

 

Jonathan Newman is a Chartered Management Accountant and is the Group Director of Finance and has over 17 years' experience in the financial services industry. Jonathan advises investee companies and has a number of non-executive appointments over three investee companies and evaluates new investment opportunities.

 

Daniel Topping is a Member of the Chartered Institute of Securities and Investment (MCSI) and an Associate of the Institute of Chartered Secretaries and Administrators (ACIS), having graduated from the University of Durham in 2005. Dan joined B.P. Marsh in February 2007 having started his career at an accountancy firm. In 2011 he was appointed as a director of B.P. Marsh and currently has a number of non-executive appointments over six investee companies and evaluates new investment opportunities.

 

Camilla Kenyon was appointed as Head of Investor Relations at B.P. Marsh in February 2009, having four years' prior experience with the Company. Camilla has a number of non-executive appointments over two investee companies, is Chair of the New Business Committee and is a Member of the Investor Relations Society.

 

Natasha Dunbar has over 18 years' experience in the financial services industry. Having joined the Company in 1994 she was made managing director in March 2002, subsequently becoming a non-executive director of the Company in 2008, a position she held for five years. Natasha was reappointed as a Director in February 2013 and holds a non-executive appointment at one of our investee companies.

 - ends -

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEELBFZVFXBBB
Date   Source Headline
28th Oct 20107:00 amRNSHalf Yearly Report
24th Sep 20107:00 amRNSNotice of Interim Results
22nd Jul 20102:23 pmRNSCompletion of U.S. Risk (UK) Limited Investment
21st Jul 201012:28 pmRNSResult of AGM
22nd Jun 20109:35 amRNSReplacement - Notice of Annual General Meeting
22nd Jun 20107:00 amRNSNotice of Annual General Meeting
10th Jun 201011:05 amRNSReplacement - Investment in U.S. Risk (UK) Limited
10th Jun 20107:00 amRNSInvestment in U.S. Risk (UK) Limited
9th Jun 20103:22 pmRNSDirectors' Loan
2nd Jun 20107:00 amRNSFinal Results
7th May 20107:00 amRNSNotice of Final Results
21st Jan 20107:00 amRNSDisposal
21st Jan 20107:00 amRNSAcquisition
11th Jan 201012:25 pmRNSDirector's Dealing
14th Dec 200910:16 amRNSDirector's Dealing
27th Oct 20097:00 amRNSInterim Results
26th Oct 20093:26 pmRNSHolding(s) in Company
30th Sep 20097:00 amRNSNotice of Interim Results
23rd Jul 200910:41 amRNSAnnual Report and Accounts
21st Jul 20097:00 amRNSResult of AGM
18th Jun 20094:07 pmRNSNotice of AGM
9th Jun 20099:28 amRNSInvestee Company, Hyperion, Announces Acquisition
3rd Jun 20097:00 amRNSLoans to Investee Company
3rd Jun 20097:00 amRNSFinal Results
18th May 20099:52 amRNSChange of Adviser
6th May 200910:58 amRNSNotice of Results
6th Apr 20093:40 pmRNSHolding(s) in Company
26th Mar 200910:11 amRNSHolding of Shares by a Director
2nd Feb 20097:00 amRNSDirectorate Change
9th Dec 20084:23 pmRNSDirector/PDMR Shareholding
4th Dec 20083:26 pmRNSDirectorate Change
3rd Dec 20084:53 pmRNSDirector/PDMR Shareholding
1st Dec 20083:05 pmRNSChange of Registered Office
18th Nov 20083:06 pmRNSDirector/PDMR Shareholding
12th Nov 200812:42 pmRNSDirector/PDMR Shareholding
28th Oct 20087:00 amRNSInterim Results
6th Oct 20082:16 pmRNSNotice of Interim Results
1st Oct 20087:00 amRNSAppointment of Nominated Adviser
24th Jul 20082:24 pmRNSResult of AGM
25th Jun 20087:00 amRNSNotice of AGM
5th Jun 20087:00 amRNSFinal Results
7th May 20082:33 pmRNSNotice of Results
2nd Apr 20089:05 amRNSHyperion partners with 3i
20th Mar 20087:00 amRNSInvestment in Trillium
11th Mar 20087:01 amRNSInvestment in Business Broker
25th Feb 20084:17 pmRNSDirectorate Change
14th Feb 20081:26 pmRNSFurther re: Disposal
12th Feb 20087:01 amRNSDisposal
4th Feb 20082:46 pmRNSIncreased Investment in Summa
27th Nov 20077:01 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.